ArticleMicrobial cell factories2026
Acetyl- and malonyl-CoA availability drive EPA selectivity in polyketide synthase-engineered Yarrowia lipolytica.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolic engineering of Escherichia coli for methanol-assisted resveratrol biosynthesis.Bioprocess and biosystems engineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe oleaginous yeast Yarrowia lipolytica is an attractive chassis for sustainable production of long‑chain ω‑3 polyunsaturated fatty acids (PUFAs). Polyketide synthase (PKS)-like PUFA synthases bypass the canonical oxygen‑dependent desaturase/elongase route, yet the influence of precursor availability on PKS product selectivity in Y. lipolytica remains unclear.
resultsHere, we explored a panel of Y. lipolytica strains comprising single‑origin (Aetherobacter fasciculatus, Minicystis rosea) and hybrid PKS clusters. A domain‑shuffled producer, Hyb6, broadened the product spectrum to penta‑unsaturated ω‑3 species, yielding EPA (18.3 mg L-1), DPA (38.8 mg L-1) and trace DHA (1.5 mg L-1) in shake flasks. Time-resolved metabolomics revealed that ω-3 accumulation began in the stationary phase, when acetyl-CoA and malonyl-CoA pools were strongly reduced. L-lysine supplementation upon glycerol depletion was associated with elevated malonyl-CoA levels, accelerated EPA formation (4.6-fold vs. control), and maintenance of an EPA/DPA ratio > 1.9. In contrast, a ketogenic amino-acid mix increased native lipids but reduced EPA selectivity. Transcriptomics revealed L-lysine‑dependent upregulation of acetyl‑CoA supply nodes (ACL1/ACL2, ACS, ACC1) and L-lysine catabolism (KAT1, GCDH, UGA2), together with induction of amino‑acid transporters and protein‑folding machinery. In fed‑batch processes, pulsed L-lysine selectively increased EPA to 405.5 mg L-1 (11.8% selectivity), with DPA at 321.5 mg L-1 and DHA at 14.0 mg L-1.
conclusionsChanges in acetyl-CoA and malonyl-CoA availability are strongly associated with EPA selectivity. Coupling modular PKS design with targeted precursor remodeling provides a versatile strategy to fine-tune product spectra in Y. lipolytica and related microbial PUFA cell factories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.